story of the week
Short-Term Therapy With a High Cannabidiol/Low Δ-9-Tetrahydrocannabinol Formulation in Patients With Parkinson's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Movement Disorders: Official Journal of the Movement Disorder Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Mov. Disord. 2024 May 01;39(5)863-875, Y Liu, J Bainbridge, S Sillau, S Rajkovic, M Adkins, CH Domen, JA Thompson, T Seawalt, J Klawitter, C Sempio, G Chin, L Forman, M Fullard, T Hawkins, L Seeberger, H Newman, D Vu, MA LeeheyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.